Showing results (331-340 of 6,988) with videos related to
Sort By:
Pageof 699
Cancer Science|February 10, 2021
Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancerYu-Chen Ma, Peng-Fei Tian, Zhi-Peng Chen, et al.Cancer Science|February 11, 2021
Signal-transducing innate receptors in tumor immunitySho Hangai, Yoshitaka Kimura, Tadatsugu Taniguchi, et al.Cancer Science|January 13, 2021
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21Minhua Deng, Wensu Wei, Jinling Duan, et al.Cancer Science|February 25, 2021
GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expressionHengxiang Cui, Wenjie Yu, Minhao Yu, et al.Cancer Science|February 7, 2017
Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseasesSugiko Watanabe, Shimpei Kawamoto, Naoko Ohtani, et al.Cancer Science|February 10, 2017
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formationShinji Takeuchi, Koji Fukuda, Tadaaki Yamada, et al.Cancer Science|March 4, 2017
Extracellular vesicles as trans-genomic agents: Emerging roles in disease and evolutionYumi Kawamura, Yusuke Yamamoto, Taka-Aki Sato, et al.Cancer Science|March 8, 2017
Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II studyMototsugu Oya, Yoshihiko Tomita, Satoshi Fukasawa, et al.Cancer Science|March 8, 2017
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphomaDai Maruyama, Kiyohiko Hatake, Tomohiro Kinoshita, et al.Cancer Science|March 26, 2017
Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II studyNaoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, et al.Pageof 699